IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Tadalafil mitigate experimental liver IschemiaReperfusion Injury in Rats via anti-oxidant, antiinflammatory and anti-apoptotic action

Author: GOMAA MOSTAFA-HEDEAB, HANYELHADY, EL-SHAYMAA EL-NAHASS, DINA SABRY
Abstract: liver ischemia reperfusion injury (IRI) represent the major causative agent of liver dysfunction following hepatectomy and liver transplantation. Reperfusion-induced liver damage is more serious than that occurred by ischemia itself. Tadalafil is a phosphodiesterase inhibitor has been used for treating essential or hypoxia-incited pulmonary hypertension in grown-ups and youngsters. Aim is to study the effect of tadalafil on IRI induced experimentally in rats. Wister Rats weighing 140–250g were classified into four groups twelve rats each; Group I: received no treatment or any surgical procedure. Group II: subjected to partial IRI only, without treatment. Group III: received Tadalafil 5 mg/kg/d orally for one week then underwent IRI. Group IV: received Tadalafil 5 mg/kg/d orally for two weeks then underwent IRI. At the end of the experiments; serum ALT, AST, Alkaline phosphatase (ALP) was estimated. The liver of each rat was taken, half for histopathological study and other half for estimation of Liver malondialdehyde (MDA), Catalase, Liver reduced glutathione (GSH), superoxide dismutase (SOD), Hemoxygenase-1 (HO-1), IL6, IL-1b, TNF-a, iNOS, eNOS and Bcl-2. Its compared to normal group; IRI significantly elevates AST, ALT and ALP, MD, TNF-a, IL6, IL-1B; while significantly decrease the HO1, BCL2. Oral administration of Tadalafil significantly decreased AST, ALT and ALP compared to IRI non-treated group, significantly increased the liver MD, TNF-a, IL6, IL-1B expression and significantly decrease the liver expression of HO1, BCL2. tadalafil can attenuate IRinduced liver injury via its anti-oxidants, anti-inflammatory and anti-apoptotic action.
Keyword: liver, reperfusion, tadalafil.
DOI: https://doi.org/10.31838/ijpr/2019.11.01.001
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477